These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2120384)

  • 21. Escherichia coli hemolysin is a potent inductor of phosphoinositide hydrolysis and related metabolic responses in human neutrophils.
    Grimminger F; Sibelius U; Bhakdi S; Suttorp N; Seeger W
    J Clin Invest; 1991 Nov; 88(5):1531-9. PubMed ID: 1658043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of arachidonic acid-derived lipoxygenase and cytochrome P450 products in the intact human lung vasculature.
    Kiss L; Schütte H; Mayer K; Grimm H; Padberg W; Seeger W; Grimminger F
    Am J Respir Crit Care Med; 2000 Jun; 161(6):1917-23. PubMed ID: 10852767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endotoxin "priming" potentiates lung vascular abnormalities in response to Escherichia coli hemolysin: an example of synergism between endo- and exotoxin.
    Walmrath D; Ghofrani HA; Rosseau S; Schütte H; Cramer A; Kaddus W; Grimminger F; Bhakdi S; Seeger W
    J Exp Med; 1994 Oct; 180(4):1437-43. PubMed ID: 7931076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe VA/Q mismatch in perfused lungs evoked by sequential challenge with endotoxin and E. coli hemolysin.
    Walmrath D; Pilch J; Scharmann M; Grimminger F; Seeger W
    J Appl Physiol (1985); 1994 Mar; 76(3):1020-30. PubMed ID: 8005841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nitric oxide biosynthesis in an exotoxin-induced septic lung model: role of cNOS and impact on pulmonary hemodynamics.
    Schütte H; Mayer K; Gessler T; Rühl M; Schlaudraff J; Burger H; Seeger W; Grimminger F
    Am J Respir Crit Care Med; 1998 Feb; 157(2):498-504. PubMed ID: 9476864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Escherichia coli hemolysin on endothelial cell function.
    Suttorp N; Flöer B; Schnittler H; Seeger W; Bhakdi S
    Infect Immun; 1990 Nov; 58(11):3796-801. PubMed ID: 2121650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. E. coli virulence factor hemolysin induces neutrophil apoptosis and necrosis/lysis in vitro and necrosis/lysis and lung injury in a rat pneumonia model.
    Russo TA; Davidson BA; Genagon SA; Warholic NM; Macdonald U; Pawlicki PD; Beanan JM; Olson R; Holm BA; Knight PR
    Am J Physiol Lung Cell Mol Physiol; 2005 Aug; 289(2):L207-16. PubMed ID: 15805136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of inflammatory mediators from human polymorphonuclear granulocytes and rat mast cells by haemolysin-positive and -negative E. coli strains with different adhesins.
    Scheffer J; Vosbeck K; König W
    Immunology; 1986 Dec; 59(4):541-8. PubMed ID: 2433215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective activation of human intestinal mast cells by Escherichia coli hemolysin.
    Krämer S; Sellge G; Lorentz A; Krueger D; Schemann M; Feilhauer K; Gunzer F; Bischoff SC
    J Immunol; 2008 Jul; 181(2):1438-45. PubMed ID: 18606698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergism of alveolar endotoxin "priming" and intravascular exotoxin challenge in lung injury.
    Walmrath D; Ghofrani HA; Grimminger F; Seeger W
    Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 1):460-8. PubMed ID: 8756823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo effects of intravascularly applied Escherichia coli hemolysin: dissociation between induction of granulocytopenia and lethality in monkeys.
    Vagts D; Dienes HP; Barth PJ; Ronneberger H; Hungerer KD; Bhakdi S
    Med Microbiol Immunol; 1993 Mar; 182(1):1-12. PubMed ID: 8497209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe microcirculatory abnormalities elicited by E. coli hemolysin in the rabbit ileum mucosa.
    Mayer K; Temmesfeld-Wollbrück B; Friedland A; Olschewski H; Reich M; Seeger W; Grimminger AF
    Am J Respir Crit Care Med; 1999 Oct; 160(4):1171-8. PubMed ID: 10508804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High yield enzymatic conversion of intravascular leukotriene A4 in blood-free perfused lungs.
    Grimminger F; Becker G; Seeger W
    J Immunol; 1988 Oct; 141(7):2431-6. PubMed ID: 2844900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergism between endotoxin priming and exotoxin challenge in provoking severe vascular leakage in rabbit lungs.
    Schütte H; Rosseau S; Czymek R; Ermert L; Walmrath D; Krämer HJ; Seeger W; Grimminger F
    Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):819-24. PubMed ID: 9309999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of cloned virulence factors (mannose-resistant haemagglutination, mannose-resistant adhesions) from uropathogenic Escherichia coli strains in the release of inflammatory mediators from neutrophils and mast cells.
    König W; König B; Scheffer J; Hacker J; Goebel W
    Immunology; 1989 Jul; 67(3):401-7. PubMed ID: 2569441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of four hemolysin-producing organisms (Escherichia coli, Serratia marcescens, Aeromonas hydrophila, and Listeria monocytogenes) for release of inflammatory mediators from various cells.
    Scheffer J; König W; Braun V; Goebel W
    J Clin Microbiol; 1988 Mar; 26(3):544-51. PubMed ID: 2451679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Escherichia coli hemolysin may damage target cell membranes by generating transmembrane pores.
    Bhakdi S; Mackman N; Nicaud JM; Holland IB
    Infect Immun; 1986 Apr; 52(1):63-9. PubMed ID: 3514465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro cytotoxic effect of alpha-hemolytic Escherichia coli on human blood granulocytes. Inhibition by alpha-hemolysin antibody.
    Gadeberg OV; Mansa B
    Zentralbl Bakteriol; 1990 Sep; 273(4):492-500. PubMed ID: 2248684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the lipopolysaccharide-CD14 complex for the activity of hemolysin from uropathogenic Escherichia coli.
    Månsson LE; Kjäll P; Pellett S; Nagy G; Welch RA; Bäckhed F; Frisan T; Richter-Dahlfors A
    Infect Immun; 2007 Feb; 75(2):997-1004. PubMed ID: 17101668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Superoxide generation by human neutrophils induced by low doses of Escherichia coli hemolysin.
    Bhakdi S; Martin E
    Infect Immun; 1991 Sep; 59(9):2955-62. PubMed ID: 1652556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.